Surgical Science Sweden AB (publ) (STO:SUS)

STO:SUS Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	943.23	884.09	882.85	802.54	366.78	104.8
Revenue Growth (YoY)	12.52%	0.14%	10.01%	118.81%	249.98%	3.23%
Cost of Revenue	303.15	286.19	269.97	271.02	100.84	16.44
Gross Profit	640.08	597.9	612.88	531.52	265.94	88.36
Selling, General & Admin	284.54	252.38	240.02	201.88	117.26	50.43
Research & Development	209.56	196.11	181.57	172.79	65.71	16.57
Other Operating Expenses	5.09	5.09	2.14	-	-	-
Operating Expenses	499.19	453.58	423.73	374.66	182.97	67
Operating Income	140.89	144.32	189.15	156.86	82.98	21.37
Interest Expense	-3.65	-0.75	-0.64	-0.54	-0.51	-0.53
Interest & Investment Income	23.16	23.96	64.73	-	-	0.22
Currency Exchange Gain (Loss)	-32.16	-4.23	15.04	5.68	-6.02	-1.39
Other Non Operating Income (Expenses)	18.2	-5.21	-0.02	46.17	18.06	-
EBT Excluding Unusual Items	146.44	158.09	268.26	208.17	94.5	19.66
Merger & Restructuring Charges	-26.5	-	-	-	-28.7	-
Pretax Income	119.94	158.09	268.26	208.17	65.8	19.66
Income Tax Expense	27.5	26.45	34.29	20.2	-20.44	4.05
Net Income	92.45	131.65	233.97	187.97	86.25	15.61
Net Income to Common	92.45	131.65	233.97	187.97	86.25	15.61
Net Income Growth	-53.24%	-43.73%	24.47%	117.95%	452.66%	23.88%
Shares Outstanding (Basic)	51	51	51	51	42	34
Shares Outstanding (Diluted)	51	51	51	51	43	34
Shares Change (YoY)	-0.02%	0.17%	0.05%	19.32%	24.14%	18.32%
EPS (Basic)	1.81	2.58	4.59	3.70	2.03	0.45
EPS (Diluted)	1.81	2.58	4.59	3.69	2.02	0.45
EPS Growth	-53.29%	-43.79%	24.39%	82.67%	348.89%	4.65%
Free Cash Flow	83.52	131.12	227.84	120.14	35.21	22.83
Free Cash Flow Per Share	1.64	2.57	4.47	2.36	0.82	0.66
Gross Margin	67.86%	67.63%	69.42%	66.23%	72.51%	84.32%
Operating Margin	14.94%	16.32%	21.43%	19.55%	22.62%	20.39%
Profit Margin	9.80%	14.89%	26.50%	23.42%	23.52%	14.89%
Free Cash Flow Margin	8.85%	14.83%	25.81%	14.97%	9.60%	21.78%
EBITDA	172.48	169.65	212.15	177.47	99	27.8
EBITDA Margin	18.29%	19.19%	24.03%	22.11%	26.99%	26.53%
D&A For EBITDA	31.58	25.33	23	20.61	16.02	6.43
EBIT	140.89	144.32	189.15	156.86	82.98	21.37
EBIT Margin	14.94%	16.32%	21.43%	19.55%	22.62%	20.39%
Effective Tax Rate	22.92%	16.73%	12.78%	9.70%	-	20.62%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.